Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis

Summary: Background: In October, 2012, Fiji introduced routine infant immunisation with a ten-valent pneumococcal conjugate vaccine (PCV10) using three primary doses and no booster dose (3 + 0 schedule). Data are scarce for the effect of PCV in the Asia and Pacific region. We aimed to evaluate the...

Full description

Bibliographic Details
Main Authors: Rita Reyburn, MSc, Evelyn Tuivaga, MBBS, Cattram D Nguyen, PhD, Felisita T Ratu, BPHN, Devina Nand, MSc, Joe Kado, MMed, Lisi Tikoduadua, MBBS, Kylie Jenkins, MPH, Margaret de Campo, MPH, Mike Kama, MPH, Rachel Devi, MPH, Eric Rafai, MPH, Daniel M Weinberger, PhD, E Kim Mulholland, ProfMD, Fiona M Russell, ProfPhD
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X20304216

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X20304216

Similar Items